These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 25524846)

  • 1. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study.
    Nabbout R; Copioli C; Chipaux M; Chemaly N; Desguerre I; Dulac O; Chiron C
    Epilepsia; 2011 Jul; 52(7):e54-7. PubMed ID: 21569025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet.
    Caraballo RH
    Epilepsia; 2011 Apr; 52 Suppl 2():79-82. PubMed ID: 21463287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
    De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
    Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacologic treatment of Dravet syndrome.
    Chiron C; Dulac O
    Epilepsia; 2011 Apr; 52 Suppl 2():72-5. PubMed ID: 21463285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketogenic diet in patients with Dravet syndrome.
    Caraballo RH; Cersósimo RO; Sakr D; Cresta A; Escobal N; Fejerman N
    Epilepsia; 2005 Sep; 46(9):1539-44. PubMed ID: 16146451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome.
    Yan N; Xin-Hua W; Lin-Mei Z; Yi-Ming C; Wen-Hui L; Yuan-Feng Z; Shui-Zhen Z
    Seizure; 2018 Aug; 60():144-148. PubMed ID: 29990707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Myers KA; Lightfoot P; Patil SG; Cross JH; Scheffer IE
    Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of young patients with Dravet syndrome after vagal nerve stimulation.
    Zamponi N; Passamonti C; Cappanera S; Petrelli C
    Eur J Paediatr Neurol; 2011 Jan; 15(1):8-14. PubMed ID: 20971664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
    Aras LM; Isla J; Mingorance-Le Meur A
    Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
    Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
    Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Landscape of Dravet Syndrome Management: An Overview.
    Samanta D
    Neuropediatrics; 2020 Apr; 51(2):135-145. PubMed ID: 32079034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ketogenic diet in the treatment of refractory status epilepticus.
    Nam SH; Lee BL; Lee CG; Yu HJ; Joo EY; Lee J; Lee M
    Epilepsia; 2011 Nov; 52(11):e181-4. PubMed ID: 22003821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.